Psychedelic medicine: a re-emerging therapeutic paradigm.
School of Population and Public Health (Tupper, Wood); Department of Medicine, Faculty of Medicine (Wood), University of British Columbia, Vancouver, BC; Department of Psychiatry and Behavioral Sciences (Johnson), Johns Hopkins University School of Medicine, Baltimore, Md.; Multidisciplinary Association for Psychedelic Studies - Canada (Yensen), Vancouver, BC; Orenda Institute (Yensen), Manson's Landing, BC.
Kenneth W
KW
Tupper
School of Population and Public Health (Tupper, Wood); Department of Medicine, Faculty of Medicine (Wood), University of British Columbia, Vancouver, BC; Department of Psychiatry and Behavioral Sciences (Johnson), Johns Hopkins University School of Medicine, Baltimore, Md.; Multidisciplinary Association for Psychedelic Studies - Canada (Yensen), Vancouver, BC; Orenda Institute (Yensen), Manson's Landing, BC uhri-ew@cfenet.ubc.ca.
Evan
E
Wood
School of Population and Public Health (Tupper, Wood); Department of Medicine, Faculty of Medicine (Wood), University of British Columbia, Vancouver, BC; Department of Psychiatry and Behavioral Sciences (Johnson), Johns Hopkins University School of Medicine, Baltimore, Md.; Multidisciplinary Association for Psychedelic Studies - Canada (Yensen), Vancouver, BC; Orenda Institute (Yensen), Manson's Landing, BC.
Richard
R
Yensen
School of Population and Public Health (Tupper, Wood); Department of Medicine, Faculty of Medicine (Wood), University of British Columbia, Vancouver, BC; Department of Psychiatry and Behavioral Sciences (Johnson), Johns Hopkins University School of Medicine, Baltimore, Md.; Multidisciplinary Association for Psychedelic Studies - Canada (Yensen), Vancouver, BC; Orenda Institute (Yensen), Manson's Landing, BC.
Matthew W
MW
Johnson
D001007:Anxiety / Q000188:drug therapy* / Q000628:therapy; D003131:Combined Modality Therapy; D006213:Hallucinogens / Q000627:therapeutic use*; D006801:Humans; D011613:Psychotherapy; D013313:Stress Disorders, Post-Traumatic / Q000188:drug therapy* / Q000628:therapy; D019966:Substance-Related Disorders / Q000188:drug therapy* / Q000628:therapy
D006213:Hallucinogens